Gefipeace 250 Tablet is an antineoplastic drug belonging to the tyrosine kinase inhibitors, containing the active ingredient Gefitinib. It is used to treat non-small cell lung cancer. Non-small cell lung cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung. It is used in patients where the NSCLC cancer has spread to other parts of the body, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment.

Some formulations of Gefipeace 250 Tablet may contain lactose as an inactive ingredient in which the body is unable to digest lactose, a sugar found in milk and dairy products. It can cause symptoms such as bloating and abdominal pain. If you have lactose intolerance, inform your doctor before starting this therapy. Talk with your healthcare provider if you have kidney or liver disease, vision problems, lung problems or are taking any blood thinner like warfarin. Your healthcare provider will check regular blood tests to prevent complications. Avoid consuming alcohol as it may cause dizziness.

Consult your doctor before using this medication if you are pregnant or plan to have a baby. Gefipeace 250 Tablet are unsafe to use during pregnancy as they cause harm to an unborn fetus. Your health care practitioner will conduct a pregnancy test before you start treatment with Gefipeace 250 Tablet. Avoid breastfeeding your baby while on the treatment as it is unknown if Gefipeace 250 Tablet passes into breast milk.

The Gefipeace 250 Tablet is used in the treatment of the following:

• Non-small cell lung cancer.

It is an anilinoquinazoline derivative which interacts with a kinase inhibitor that inhibits an abnormal protein called the epidermal growth factor receptor (EGFR). This helps to slow or stop the growth of cancer cells and reduce the size of tumours in patients with NSCLC.

Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Gefipeace 250 Tablet and reduce effectiveness by causing undesirable side effects. 

• Store Gefipeace 250 Tablet in the original package at room temperature (25°C).

• Keep it out of reach from children.

Gefipeace 250 Tablet is available as a tablet to be taken with or without food, as directed by your healthcare provider. The usual recommended dosage is 250 mg tablet once daily. Avoid crushing, opening, or dissolving the tablet; swallow it whole with a glass of water. Take the Gefipeace 250 Tablet at the same time every day.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Common side effects of Gefipeace 250 Tablet are:

• Diarrhea

• Nausea

• Vomiting

• Loss of appetite

• weakness

• Red or sore mouth

• increased liver enzymes

• itchy or cracked skin

• dry mouth

• Red or itchy eyes

• nail problems

• hair loss

• fever

• Blood in the urine and a burning sensation while urinating.

• Gefipeace 250 Tablet is not recommended for children and adolescents below 18 years.

• Regular monitoring of blood pressure is advised during treatment.

• Do not take antacids two hours before or one hour after taking this tablet.

• Avoid driving or operating heavy machinery if you experience tiredness or weakness while on treatment.